Search form

Research and development within life science in Stockholm is gathered under the Stockholm Life brand.

May 30 2017

Seminar highlighting Sweden’s strength within life science

On May 2nd the Government Offices of Sweden hosted a seminar highlighting Sweden’s strength within the life science area. Many of the presentations highlighted the good environment in Stockholm-Uppsala and the excellent environment offered it the European Medicines Agency would be located in the region.

May 29 2017

Life science seminar in Almedalen

Stockholm Science City organises a seminar on July 4th in Almedalen together with H2 Health Hub and Life Science Sweden. The seminar will adress the ongoing transformation of the pharmaceutical industry where many pharmaceutical companies are moving from mainly producing products for sick people to develop products to keep people healthy. How does this affect the relationship between caregiver and pharmaceutical companies and between caregiver and patient?

Björn Varnestig, CEO, Flemingsberg Science
May 29 2017

Flemingsberg - a place where knowledge drives business

Flemingsberg Science creates synergies for research and innovation in Flemingsberg. A part of the vision for Flemingsberg is to make it to a place where knowledge drives business. Björn Varnestig, CEO at Flemingsberg Science, tells us about what the foundation is up to right now and what is going to happen during 2017. 

May 23 2017

The Swedish government wants EMA to be located in Hagastaden

As a consequence of Brexit, the European Medicines Agency (EMA) will leave London and establish its activities elsewhere within the EU. It is believed that this will happen before the end of March 2019 when the process for the UK to leave the EU is concluded. The Swedish government wants EMA to be relocated to Hagastaden and Stockholm Science City assists the Government Offices of Sweden on the candidature. 

May 19 2017

September 28-October 5: Join the Nordic Delegation at Health 2.0

Thursday, 28 September, 2017 - 11:15 to Thursday, 5 October, 2017 - 17:00

For companies developing new innovative technologies across health care and wellness, the Annual Health 2.0 Fall Conference is the place to be each year. After successfully piloting last year, Nordic Innovation House, together with HealthTech Nordic, offer a special opportunity for qualified startups from the Nordics to participate in Health 2.0. 

May 19 2017

Innovation course autum 2017: To be an innovator and entrepreneur in medical technology

Wednesday, 18 October, 2017 - 09:15 to Thursday, 9 November, 2017 - 18:00

Medtech4Health is once again arranging the course "To be an innovator and entrepreneur in medical technology". The course targets those who want to learn more about the innovation and entrepreneur process in medical technology. During four days, October 18-19 in Umeå and November 8-9 in Linköping, you will learn about the entire process, from identifying a problem in health care to commercializing a product. 

May 16 2017

November 14th 2017, full day seminar: Exit strategies for drug development projects, Karolinska Institutet Science Park

Tuesday, 14 November, 2017 - 08:00 to 17:00

How do you plan a drug development project from the start in order to meet the demands on both quality as well as planning from a potential investor or partner? What key issues are important from a investor or partner perspective? The seminar is aimed towards people in decision-making positions at all levels of the smaller pharmaceutical company.

May 16 2017

October 4th 2017, full day seminar: Statistics in Clinical Trials – Design and Decision Making

Wednesday, 4 October, 2017 - 08:00 to 17:00

The seminar is focused on discussing trial design and strategies related to decision making in clinical trial programs. Potential participants are medical directors, clinical program leaders, statisticians and regulatory affairs professionals. 

May 12 2017

Affibody To Initiate Phase II Psoriasis Trials For Lead Candidate ABY-035

Affibody has announced that it has decided to initiate Phase II development with ABY-035, which is the company’s proprietary psoriasis program.

May 12 2017

The first comprehensive map of the subcellular localization of human proteins reveals new insights in human biology


The first analysis of how proteins are arranged in a cell was published today in Science, revealing that a large portion of human proteins can be found in more than one location in a given cell. Using the Sweden-based Cell Atlas, researchers examined the spatial distribution of the human proteome that correspond to the majority of protein-coding genes, and they described in unprecedented detail the distribution of proteins to the various organelles and substructures of the human body’s smallest unit, the cell.